We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
Source: CNBC Markets ·
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
Read the full story at CNBC Markets
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.